Aflibercept

Also known as Eylea (us)

Save $1,114,551/mo

119× cheaper

Aflibercept injection is used to treat: wet age-related macular degeneration (AMD; an ongoing disease of the eye that causes loss of the ability to see straight ahead and may make it more difficult to read, drive, or perform other daily activities) diabetic macular edema (an eye disease caused by di…

United States

$1,123,960

per month

India

$9,409

per month

You save

$1,114,551

99.16% cheaper in India

32.8K US scripts/yr$36.5B potential annual savings$36.8B US spend/yr

3D structure coming soon

Resolve it by running structure:fetch

Compare the price

US price$1,123,960per month

India price$9,409per month

You save$1,114,55199.16% less

Based on 30 units per month. US $37,465.32 vs India $313.62 per unit.

How many months / courses?

Total over 1 periodSave $1,114,551$1,123,960 → $9,409

Is travelling to India worth it?

The savings here are large enough that a trip may still come out ahead. Adjust the numbers to your own situation — every value is an editable estimate.

Months of medicine

Round-trip flights ($)

Hotel / night ($)

Nights of stay

Extra buffer ($)

Medicine savings over 6 months: $6,687,306
Estimated travel cost: − $2,300
Net savings after travel: $6,685,006

Even after travel, you could come out ahead by about $6,685,006.

Assumptions: medicine savings = (US − India monthly price) × months. Travel cost = flights + hotel × nights + buffer. Excludes consultation fees, visas, and other costs. For information only — not medical, legal, or travel advice.

The bigger picture

Aflibercept is filled about 32.8K times a year under Medicare Part D. At the prices above, that works out to roughly:

Est. annual US spend

$36.8B

If sourced from India

$308.3M

Potential annual savings

$36.5B

−99%

Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.